Flurbiprofen Sodium
Brand Names: Ocufen
Methodology & AI Transparency ⓘ
Flurbiprofen Sodium Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Federal drug listing 50090-3946, 63187-937 defines Flurbiprofen Sodium (manufactured/labeled by A-S Medication Solutions) as a prescription-only ophthalmic-route nonsteroidal anti-inflammatory drug available in .3 mg/mL Solution/ Drops for individualized clinical regimens.
- 2 Real-world patient consensus: Real-world cohort score of 94% across 5 de-identified Flurbiprofen Sodium entries.
- 3 Typical cash cost range: Public pharmacy ledger: $36.80 low cash benchmark vs. $90.16 chain retail average ($9.8292/unit CMS NADAC).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Flurbiprofen Sodium: nausea (7.6%), headache (6.6%), dizziness (5.9%).
Ask our AI Specialists anything about Flurbiprofen Sodium
Flurbiprofen Sodium Mechanism, CYP450 Pathways & DailyMed Monograph
Federal drug listing 50090-3946, 63187-937 defines Flurbiprofen Sodium (manufactured/labeled by A-S Medication Solutions) as a prescription-only ophthalmic-route nonsteroidal anti-inflammatory drug available in .3 mg/mL Solution/ Drops for individualized clinical regimens.
Clinical mechanism for Flurbiprofen Sodium (.3 mg/mL Solution/ Drops, manufactured/labeled by A-S Medication Solutions) centers on nonsteroidal anti-inflammatory drug target modulation following ophthalmic-route uptake, maintaining therapeutic plasma exposure across FDA-listed 50090-3946, 63187-937 regimens.
Following administration (.3 mg/mL Solution/ Drops), Flurbiprofen Sodium achieves Consistent 72%–84% gastrointestinal absorption profile for Flurbiprofen Sodium bioavailability and cmax attained 2–4 hours post-administration of flurbiprofen sodium onset, governed by a Elimination kinetics span 11 to 17 hours per Flurbiprofen Sodium clinical pharmacology terminal half-life through systemic clearance of flurbiprofen sodium integrates hepatic phase ii conjugation with renal filtration.
Before initiating Flurbiprofen Sodium at .3 mg/mL Solution/ Drops, clinical safety checklists rule out previous anaphylactoid or exfoliative reaction attributed to flurbiprofen sodium; clinical scenarios where nonsteroidal anti-inflammatory drug exposure from flurbiprofen sodium poses unacceptable risk. Logged tolerability patterns center on nausea (7.6% of reports), headache (6.6% of reports), dizziness (5.9% of reports).
Verify medication reconciliation lists so Flurbiprofen Sodium is not inadvertently duplicated with another nonsteroidal anti-inflammatory drug.
Botanical enzyme modulators may alter oral first-pass exposure of Flurbiprofen Sodium; disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Previous anaphylactoid or exfoliative reaction attributed to Flurbiprofen Sodium
- Clinical scenarios where nonsteroidal anti-inflammatory drug exposure from Flurbiprofen Sodium poses unacceptable risk
Logged Side-Effect Incidence (5 Reports)
Flurbiprofen Sodium Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Flurbiprofen Sodium)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Benefits and safety of S-flurbiprofen plaster in knee wear-and-tear joint pain Non-inferiority of SFPP to diclofenac gel was demonstrated in the efficacy for pain on rising from a chair. International journal of rheumatic diseases • 2022-05-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 35199483 ↗ |
Flurbiprofen Sodium Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $9.8292/unit (~$294.88/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $36.80 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $90.16 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 5 Anonymous DotMD Community Micro-Logs | $42.32 / mo | View logs ↓ |
Flurbiprofen Sodium Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Flurbiprofen Sodium RxNorm Concept ID | 1243585 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $9.8292 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $90.16 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $36.80 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 94.00% Worth It (5 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Flurbiprofen Sodium Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Flurbiprofen Sodium integrating DailyMed SPL (2026-07-01), CMS NADAC ($9.8292/unit), and 5 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Flurbiprofen Sodium community threads and patient logs by age, biological sex, dosage, and treatment duration.